These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7308257)

  • 1. Appearance of iron free hyperplastic hepatocytes following ferric nitrilotriacetate and 2-acetaminofluorene sequential administration.
    Malvaldi G
    Eur J Cancer (1965); 1981 Apr; 17(4):481-3. PubMed ID: 7308257
    [No Abstract]   [Full Text] [Related]  

  • 2. [Induction, characterization and isolation of preneoplastic hepatocytes following combined treatment with 2-acetaminofluorene and ferric nitrilotriacetate].
    Bibbiani C; Malvaldi G
    Boll Soc Ital Biol Sper; 1981 Aug; 57(16):1722-6. PubMed ID: 6118169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formation of 8-hydroxydeoxyguanosine (8-OH-dG) in rat kidney DNA after intraperitoneal administration of ferric nitrilotriacetate (Fe-NTA).
    Umemura T; Sai K; Takagi A; Hasegawa R; Kurokawa Y
    Carcinogenesis; 1990 Feb; 11(2):345-7. PubMed ID: 2302761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of acute and sub-chronic administration of iron nitrilotriacetate in the rat.
    Preece NE; Hall DE; Howarth JA; King LJ; Parke DV
    Toxicology; 1989 Nov; 59(1):37-58. PubMed ID: 2573173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephrotoxicity and its prevention by vitamin E in ferric nitrilotriacetate-promoted lipid peroxidation.
    Okada S; Hamazaki S; Ebina Y; Li JL; Midorikawa O
    Biochim Biophys Acta; 1987 Oct; 922(1):28-33. PubMed ID: 3663701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute structural changes in renal tubular epithelium following administration of nitrilotriacetate.
    Merski JA
    Food Cosmet Toxicol; 1981 Aug; 19(4):463-70. PubMed ID: 7274880
    [No Abstract]   [Full Text] [Related]  

  • 7. Increase of lipid hydroperoxides in the rat liver and kidney after administering ferric nitrilotriacetate.
    Ikeda K; Sun F; Tanaka K; Tokumaru S; Kojo S
    Biosci Biotechnol Biochem; 1998 Jul; 62(7):1438-9. PubMed ID: 9720229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutagenic effects of ferric nitrilotriacetate (Fe-NTA) on V79 Chinese hamster cells and its inhibitory effects on cell-cell communication.
    Nakatsuka S; Tanaka H; Namba M
    Carcinogenesis; 1990 Feb; 11(2):257-60. PubMed ID: 2302753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uptake of iron and nitrilotriacetate (NTA) in rat liver and the toxic effect of Fe-NTA.
    Matsuura R
    Acta Med Okayama; 1983 Oct; 37(5):393-400. PubMed ID: 6316757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of zinc in nitrilotriacetate(NTA)-associated renal tubular cell toxicity.
    Anderson RL
    Food Cosmet Toxicol; 1981 Oct; 19(5):639-50. PubMed ID: 7308907
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pathogenesis and mechanism of iron overload: ferric nitrilotriacetate, hemosiderin, active oxygen, and carcinogenesis].
    Awai M
    Rinsho Ketsueki; 1989 Aug; 30(8):1115-27. PubMed ID: 2689676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translocation of Bax in rat hepatocytes cultured with ferric nitrilotriacetate.
    Yajun Z; Hongshan C; Baoxi S; Dengbing Y; Jianhua S; Xinshun G; Li Y; Yi C
    Life Sci; 2005 Apr; 76(24):2763-72. PubMed ID: 15808878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of iron toxicity in the liver and pancreas after a single injection of ferric nitrilotriacetate.
    Yamanoi Y; Matsuura R; Awai M
    Nihon Ketsueki Gakkai Zasshi; 1982 Dec; 45(7):1229-35. PubMed ID: 7168306
    [No Abstract]   [Full Text] [Related]  

  • 14. Reversibility of nephrotoxicity induced in rats by nitrilotriacetate in subchronic feeding studies.
    Myers MC; Kanerva RL; Alden CL; Anderson RL
    Food Chem Toxicol; 1982 Dec; 20(6):925-34. PubMed ID: 6891677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of renal tissue structure during a 30-day gavage study with nitrilotriacetate.
    Merski JA
    Food Chem Toxicol; 1982 Aug; 20(4):433-40. PubMed ID: 6890021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental iron overload using ferric nitrilotriacetate (Fe3+-NTA): a proposal model of the diseases in man caused by iron overload.
    Awai M
    Nihon Ketsueki Gakkai Zasshi; 1986 Dec; 49(8):1650-9. PubMed ID: 3564852
    [No Abstract]   [Full Text] [Related]  

  • 17. [The morphology of kidney tumors induced in rats by iron nitrilotriacetate].
    Turkevich EA; Petrov AS; Vorob'ev AV
    Vopr Onkol; 1992; 38(6):753-6. PubMed ID: 1300779
    [No Abstract]   [Full Text] [Related]  

  • 18. Liver, kidney, and central nervous system toxicity of aluminum given intraperitoneally to rats: a multiple-dose subchronic study using aluminum nitrilotriacetate.
    Ebina Y; Okada S; Hamazaki S; Midorikawa O
    Toxicol Appl Pharmacol; 1984 Sep; 75(2):211-8. PubMed ID: 6433509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of glutathione depletion, chelation and diuresis on iron nitrilotriacetate-induced lipid peroxidation in rats and mice.
    Preece NE; Evans PF; King LJ; Parke DV
    Xenobiotica; 1990 Sep; 20(9):879-86. PubMed ID: 2238709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ferric nitrilotriacetate (Fe3+-NTA) produces active oxygens and induces malignant transformation on cultured rat liver cells].
    Awai M
    Tanpakushitsu Kakusan Koso; 1988 Dec; 33(16):2844-54. PubMed ID: 2855152
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.